Foliglurax, a positive allosteric modulator of the metabotrophic glutamate receptor 4, protects dopaminergic neurons in MPTP-lesioned male mice
- 25 March 2023
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1809, 148349
Abstract
No abstract availableKeywords
Funding Information
- H. Lundbeck A/S
This publication has 45 references indexed in Scilit:
- A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's DiseaseThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6‐hydroxydopamine rat model of Parkinson's diseaseBritish Journal of Pharmacology, 2012
- Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatmentJournal of Neurochemistry, 2009
- Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Molecular Pharmacology, 2008
- NEUROPROTECTIVE EFFECTS OF A SELECTIVE N‐METHYL‐d‐ASPARTATE NR2B RECEPTOR ANTAGONIST IN THE 6‐HYDROXYDOPAMINE RAT MODEL OF PARKINSON'S DISEASEClinical and Experimental Pharmacology and Physiology, 2008
- Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6‐hydroxydopamine‐lesioned ratsJournal of Comparative Neurology, 2008
- Pharmacological Activation of mGlu4 Metabotropic Glutamate Receptors Reduces Nigrostriatal Degeneration in Mice Treated with 1-Methyl-4-Phenyl-1,2,3,6-TetrahydropyridineJournal of Neuroscience, 2006
- Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyondNature Reviews Drug Discovery, 2006
- Group III Metabotropic Glutamate-Receptor-Mediated Modulation of Excitatory Transmission in Rodent Substantia Nigra Pars Compacta Dopamine NeuronsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's diseaseAnnals of Neurology, 2001